首页 › 基金 › Bain Capital Life Sciences Investors, LLC › OLMA
Bain Capital Life Sciences Investors, LLC 对 OLMA 的持仓历史
OLEMA PHARMACEUTICALS INC · 医疗保健
Bain Capital Life Sciences Investors, LLC 在 Q3 2026 的 13F 申报中披露持有 OLMA(OLEMA PHARMACEUTICALS INC)7,085,249 股,市值约 US$61.2M,约占其申报组合的 4.21%,在其申报持仓中市值排名第 10 位。 Bain Capital Life Sciences Investors, LLC 最近 8 个申报季度中有 8 个季度披露了 OLMA 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Bain Capital Life Sciences Investors, LLC 对 OLMA 的持仓演变
Bain Capital Life Sciences Investors, LLC 于 Q4 2024 首次披露 OLMA 持仓:7,470,214 股(约 US$43.6M)。 该持仓在 Q4 2025 达到峰值 8,508,641 股,市值约 US$212.7M。 在 8 次申报中,Bain Capital Life Sciences Investors, LLC 1 次增持、3 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 7,085,249 股、市值约 US$61.2M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 7.47M | $43.55M | 新进 |
| Q1 2025 | 6.84M | $25.73M | 减持 |
| Q2 2025 | 6.84M | $29.16M | 持有 |
| Q3 2025 | 6.84M | $67.00M | 持有 |
| Q4 2025 | 8.51M | $212.72M | 增持 |
| Q1 2026 | 7.47M | $111.43M | 减持 |
| Q2 2026 | 7.09M | $88.64M | 减持 |
| Q3 2026 | 7.09M | $61.22M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 OLMA 与 13F 数据
OLMA(OLEMA PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 31 只申报持有 OLMA,申报仓位最大的包括:Paradigm Biocapital Advisors LP (US$75.3M), BVF INC/IL (US$66.3M), Siren, L.L.C. (US$42.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 OLMA 的基金
- Paradigm Biocapital Advisors LP 8.72M 股 · $75.35M · Q3 2026
- BVF INC/IL 5.30M 股 · $66.25M · Q2 2026
- Siren, L.L.C. 4.86M 股 · $41.96M · Q3 2026
- Logos Global Management LP 3.21M 股 · $27.72M · Q3 2026
- Cormorant Asset Management, LP 2.15M 股 · $26.90M · Q2 2026
- Lightspeed Management Company, L.L.C. 1.36M 股 · $11.71M · Q3 2026
- Defilade Capital Management, L.P. 924.76K 股 · $11.57M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 1.20M 股 · $10.37M · Q3 2026
更多关于 Bain Capital Life Sciences Investors, LLC
常见问题
How long has Bain Capital Life Sciences Investors, LLC held OLMA?
Bain Capital Life Sciences Investors, LLC has disclosed OLMA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Bain Capital Life Sciences Investors, LLC's current position in OLMA?
As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 7.09M shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $61.22M, representing 4.21% of its reported portfolio and ranking #10.
Has Bain Capital Life Sciences Investors, LLC been buying or selling OLMA?
In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC held unchanged its position in OLMA. The position peaked in Q4 2025 at 8.51M shares.
Which other funds hold OLMA?
Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, BVF INC/IL, Siren, L.L.C., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.